Exact Sciences to Participate in J.P. Morgan Healthcare Conference
Exact Sciences (Nasdaq: EXAS), a leading cancer screening and diagnostic tests provider, has announced its participation in the upcoming J.P. Morgan Healthcare Conference in San Francisco. The company's management will deliver a presentation followed by a Q&A session on Monday, January 13, 2025, at 1:30 p.m. ET.
Investors and interested parties can access the webcast through the investor relations section of Exact Sciences' website at www.exactsciences.com.
Exact Sciences (Nasdaq: EXAS), un'importante fornitore di screening e test diagnostici per il cancro, ha annunciato la sua partecipazione alla prossima J.P. Morgan Healthcare Conference che si terrà a San Francisco. La direzione dell'azienda presenterà un intervento seguito da una sessione di domande e risposte lunedì 13 gennaio 2025, alle 13:30 ET.
Gli investitori e i soggetti interessati possono accedere alla trasmissione web attraverso la sezione relazioni con gli investitori del sito di Exact Sciences all'indirizzo www.exactsciences.com.
Exact Sciences (Nasdaq: EXAS), un proveedor líder de pruebas de detección y diagnóstico del cáncer, ha anunciado su participación en la próxima J.P. Morgan Healthcare Conference en San Francisco. La dirección de la empresa realizará una presentación seguida de una sesión de preguntas y respuestas el lunes 13 de enero de 2025, a la 1:30 p.m. ET.
Los inversionistas y partes interesadas pueden acceder a la transmisión web a través de la sección de relaciones con inversionistas del sitio de Exact Sciences en www.exactsciences.com.
엑삭트 사이언스 (Nasdaq: EXAS)는 암 검진 및 진단 테스트의 선도적인 제공업체로서 샌프란시스코에서 열리는 J.P. 모건 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 회사 경영진은 2025년 1월 13일 월요일, 오후 1시 30분 ET에 발표를 하고, 이어서 질문 및 답변 시간을 가질 예정입니다.
투자자 및 관심 있는 모든 분들은 엑삭트 사이언스 웹사이트 www.exactsciences.com의 투자자 관계 섹션을 통해 웨비나에 접속할 수 있습니다.
Exact Sciences (Nasdaq: EXAS), un fournisseur leader de tests de dépistage et de diagnostic du cancer, a annoncé sa participation à la prochaine J.P. Morgan Healthcare Conference à San Francisco. La direction de l'entreprise présentera une intervention suivie d'une session de questions-réponses le lundi 13 janvier 2025, à 13h30 ET.
Les investisseurs et les parties intéressées peuvent accéder au webinaire via la section relations investisseurs du site de Exact Sciences à l'adresse www.exactsciences.com.
Exact Sciences (Nasdaq: EXAS), ein führender Anbieter von Krebs-Screenings und Diagnosetests, hat seine Teilnahme an der kommenden J.P. Morgan Healthcare Conference in San Francisco bekannt gegeben. Das Management des Unternehmens wird am Montag, den 13. Januar 2025, um 13:30 Uhr ET eine Präsentation halten, gefolgt von einer Fragerunde.
Investoren und Interessierte können über den Bereich Investor Relations der Website von Exact Sciences auf den Webcast zugreifen unter www.exactsciences.com.
- None.
- None.
-
J.P. Morgan Healthcare Conference,
San Francisco
Presentation followed by Q&A on Monday, January 13, 2025 at 1:30 p.m. ET
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250102318458/en/
Erik Holznecht
Exact Sciences Corp.
investorrelations@exactsciences.com
608-800-6605
Source: Exact Sciences Corp.
FAQ
When is Exact Sciences (EXAS) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors access Exact Sciences' (EXAS) J.P. Morgan Healthcare Conference presentation?
Where will the 2025 J.P. Morgan Healthcare Conference featuring Exact Sciences (EXAS) be held?
What type of session will Exact Sciences (EXAS) conduct at the 2025 J.P. Morgan Healthcare Conference?
